Zero Coupon Pharmacy DST
sponsored by Inland Private Capital
Zero Coupon Pharmacy DST, sponsored by Inland Private Capital, filed its first Form D with the SEC on Sep 26, 2012 for a $4.3 million offering. Its last Form D, filed Jan 29, 2013, reports the offering fully sold.
How it ended
The last Form D, filed Jan 29, 2013, reports the offering fully sold.
Key facts
- Minimum investment
- $25,000From the Form D
- Offering size
- $4,383,411Equity offered, per the Form D
- Sold
- 100%Form D, Jan 29, 2013; the % is our arithmetic
- Investors reported
- Form D, Jan 29, 201344
- Selling commissions
- Form D Item 15; the % is our arithmetic$306,839 · 7.0% of offering
- Financing
- Zero coupon. Cash flow from the property goes to servicing the debt.How it is financed ↓
- Offered under
- Rule 506(b)General advertising and solicitation are not permitted under this exemption.
Figures come from SEC Form D filings unless a source is cited. Sponsor-stated figures are as reported by the sponsor; Top1031 does not independently audit them. On a 45-day clock? Find day 45 and day 180 →
Using this record to judge the sponsor? A licensed 1031 specialist from our affiliated partner can talk it through with you.
Ask a 1031 specialist about this recordFree. About: Zero Coupon Pharmacy DST. Top1031 is not a broker-dealer.What did Zero Coupon Pharmacy DST own?
Public filings never identify the property. The initial Form D describes the securities only as beneficial interests in a Delaware statutory trust reflecting beneficial interests in real estate — no address, tenant, building size or acquisition detail appears anywhere in the record. 2 Reviewed zero-coupon coverage points toward Inland's Pharmacy Portfolio III and IV programs, but no source links either name or any specific building to this Trust's filings.
How was it financed, and what did it cost to sell?
Zero-coupon — also called zero cash flow — financing means the loan is sized so that essentially all rent from the property services the debt, leaving investors little or no current income while principal amortizes over the loan term. Public filings for this Trust name no lender and disclose no loan balance.
Debt
- Financing
- Zero coupon. Cash flow from the property goes to servicing the debt.
Costs and terms from the Form D
- Selling commissions
- $306,839 · 7.0% of offering
- Finders’ fees
- $0
- Paid to officers, directors and promoters
- $598,709 · 13.6% of offeringForm D Item 16
- Broker-dealers named in the Form D
- 14 named in the Form D
Show the firms
- Ameritas Investment Company, LLC · CRD 14869
- Centaurus Financial, Inc. · CRD 30833
- Colorado Financial Service Corporation · CRD 104343
- Concorde Investment Services, LLC · CRD 151604
- DFPG Investments, LLC · CRD 155576
- H. Beck, Inc. · CRD 1763
- Independent Financial Group, LLC · CRD 7717
- Inland Securities Corporation · CRD 15807
- Investacorp, Inc. · CRD 7684
- JRL Capital Corporation · CRD 10225
- McDermott Investment Services, LLC · CRD 154926
- Sandlapper Securities, LLC · CRD 137906
- Sigma Financial Corporation · CRD 14303
- Triad Advisors LLC · CRD 25803
Individual representatives named in Item 12 are not listed.
- Date of first sale
- Sep 20, 2012
- Minimum investment
- $25,000
Form D Item 15 and Item 16 amounts may be the issuer’s estimates; each percentage is Top1031’s arithmetic on two Form D figures. Item 16 can overlap Item 15, so Top1031 does not add them together. The issuer marked these amounts as an estimate.
Who's behind Zero Coupon Pharmacy DST?
The issuer filed from 2901 Butterfield Road, Oak Brook, Illinois, the address of record for both mailing and business contact. 1 The sponsor is a long-running DST program sponsor with a large back catalogue of 1031 exchange offerings and a small number still raising. On July 14, 2022 Inland Private Capital announced it had monetized its first zero-coupon offerings, Pharmacy Portfolio III DST and Pharmacy Portfolio IV DST, reporting total returns over 265%; that release names those two programs, not this Trust.
- Sponsor
- Offerings on record
What does the SEC record show?
Six Form D notices run from September 2012 to January 2013, each amendment restating the running subscription figures, and nothing has been filed for this Trust since. 3 Because it was sold privately without public advertising, no prospectus exists — the operative terms sit in the offering documents.
- Legal Trust name
- Zero Coupon Pharmacy DST
- SEC CIK
- 1558967
- First Form D
- Sep 26, 2012
- Latest Form D
- Jan 29, 2013
- Filings on record
- 6
- Offered under
- Rule 506(b)General advertising and solicitation are not permitted under this exemption.
- Source filing
SEC Form D filings, newest first
| Filed | Form | Offering amount | Amount sold | Investors | Filing on SEC EDGAR |
|---|---|---|---|---|---|
| Form D/A | $4,383,411 | $4,383,411+$464,095 | 44+4 | EDGAR | |
| Form D/A | $4,383,411 | $3,919,316+$360,902 | 40+5 | EDGAR | |
| Form D/A | $4,383,411 | $3,558,414+$1,207,502 | 35+12 | EDGAR | |
| Form D/A | $4,383,411 | $2,350,912+$1,008,519 | 23+8 | EDGAR | |
| Form D/A | $4,383,411 | $1,342,393+$1,263,400 | 15+13 | EDGAR | |
| Form D | $4,383,411 | $78,993 | 2 | EDGAR |
Amounts, investor counts and minimums are as filed with the SEC on Form D. The change lines are Top1031’s arithmetic between consecutive filings; a new Form D notice starts a new count.
A Form D is the notice a sponsor files when it starts raising money. A Form D filing does not mean the SEC approved, endorsed, or verified the offering.
Common questions
- What happened to Zero Coupon Pharmacy DST?
- Zero Coupon Pharmacy DST is a Historical offering. The last Form D, filed Jan 29, 2013, reports the offering fully sold.
- What does "zero coupon" mean in a DST?
- A zero-coupon (or zero cash flow) DST is financed with a loan sized so that essentially all rent from the property goes to debt service. Investors typically receive little or no current cash distribution during the hold; the economics rest on principal amortization and whatever happens at sale, refinancing or loan maturity.
- What property did this Trust own?
- The public record does not say. The Form D filings describe only beneficial interests in a Delaware statutory trust reflecting interests in real estate, without an address, tenant or square footage. The trust name suggests pharmacy retail, but no source located links a specific building or tenant to this filer.
- Is this the same as Inland's Pharmacy Portfolio III or IV DST?
- No source establishes that. Inland Private Capital's July 14, 2022 release on monetizing its first zero-coupon offerings names Pharmacy Portfolio III DST and Pharmacy Portfolio IV DST — different offering names from this Trust. Whether they share underlying assets is not something public filings settle.
- Has the sponsor reported an outcome for this Trust?
- No outcome specific to Zero Coupon Pharmacy DST has been reported in the sources reviewed. The SEC record for this filer ends with the January 29, 2013 Form D amendment, and no later disposition, refinancing or amendment for this exact entity was located as of August 17, 2026.
- How was the offering sold?
- Through a private placement to accredited investors — people meeting SEC income or net-worth thresholds — under Rule 506(b), which permits no general advertising or public solicitation. Subscriptions were reported to the SEC on Form D and its amendments rather than through a registered prospectus.
Sources
Show sources (5)Hide sources (5)
These links support the record as a whole; individual details may come from different sources.
DST interests are illiquid private securities. You may lose some or all of your investment. Distributions, tax treatment, and exit timing are not guaranteed. Review the current offering documents before investing.